Kruszewski et al (20) reported HER-2 overexpression in 27% of 202 CRC patients, while Kavanagh et al (12) observed overexpression in 11% of 132 patients using IHC performed on whole sections. The gene discussed is ERBB2; the disease is colorectal carcinoma.